VERRUCA REVIEW
Subjective:
Patient reports mild discomfort following the last treatment, describing a slight stinging sensation for a few hours after the salicylic acid application. They confirm they have been keeping the dressings dry and changing them every other day as instructed.
Objective:
The verruca lesion is located on the plantar aspect of the left foot, with one lesion present. The lesion presents with hyperkeratosis and visible capillary endings. After debridement, the lesion's skin line patterns are more visible, and there is slight bleeding at the site.
Assessment:
Debridement of the lesion was performed using a scalpel. Salicylic acid was applied to the verruca site.
Plan:
Follow-up appointment scheduled for 2 weeks from today, on 15 November 2024. Treatment is estimated to continue for approximately 6-8 weeks, depending on the response to treatment. At the next consultation, further debridement and salicylic acid application will be performed.
VERRUCA REVIEW
Subjective:
[State how patient responded to last treatment with regards to any pain, discomfort, or difficulties encountered as a result of treatment. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[State whether adherence to recommended treatment or advice was followed if applicable such as keeping dressings dry, changing dressings, applying acid, keeping covered, wearing footwear in shared facilities, taking zinc supplement, otherwise omit. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention other significant medical history such as other supplements/medication taken or medical conditions. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention any social impact of foot condition such as non-participation in sport, change in activities, change in footwear. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
Objective:
[State where the verruca lesion is located on the foot, and how many present on the feet. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Describe appearance of lesion at the start of today's consultation including hyperkeratosis, capillary endings, blistering, depth, or other notable features mentioned by the clinician. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention whether any other verruca lesions present elsewhere on the body if discussed, otherwise omit. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
Assessment:
[Mention debridement of lesion if scalpel has been used. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Describe any changes to appearance of lesion that have evolved after debridement of the lesion during this appointment only such as skin line patterns, depth of lesion, bleeding sites, surrounding skin condition, development of wound etc. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention any chemicals that are applied to the verruca sites including liquid nitrogen, trichloroacetic acid, salicylic acid, or silver nitrate. If liquid nitrogen applied state how many applications used and how long each application lasted. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention any dressings that were applied such as cutiplast, rigid strapping tape, apertured rigid tape, overlying rigid tape, hypafix, Rock Tape. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention whether offloading semi-compressed felt padding is applied to the foot and how long it is instructed to stay in place for. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention any further education, instructions or recommended advice given to patient for current condition. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
Plan:
[Mention when follow-up appointment is scheduled. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention how long treatment is estimated to be continued for. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
[Mention plan for next consultation if discussed. (Only include if explicitly mentioned in the transcript, contextual notes or clinical note; otherwise omit completely.)]
(For each section, only include if explicitly mentioned in transcript or context, else omit section entirely. Never come up with your own patient details, assessment, plan, interventions, evaluation, or next steps—use only the transcript, contextual notes, or clinical note as reference for all information. If any information related to a placeholder has not been explicitly mentioned, do not state that in the output; simply leave the relevant placeholder or section out entirely. Use as many lines, paragraphs, or bullet points as needed to capture all relevant information from the transcript.)
